Endometriosis

Paul Berveiller, Christian M. Becker, Berveiller P, Stanislas Ropert, Ropert S, Stacey A. Missmer, Krina T. Zondervan, Olivier Mir, Mir O
New England Journal of Medicine · 2020 · vol. 383(2) , pp. 193–194 · doi:10.1056/nejmc2013221 · PMID:32640139 · W4230923619
Other OA: closed CC0 ⤵ 12 in-corpus citations
🔓 Open OA copy Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash+body, 2026-11-05 ⓘ

This letter serves as an author reply to a previous publication in the New England Journal of Medicine regarding endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-05 · read from full text ⓘ

This letter serves as a response to previous correspondence published in the New England Journal of Medicine, addressing specific critiques or comments regarding endometriosis research. The authors defend their prior findings or methodology, engaging in scientific debate within the journal's correspondence section rather than presenting new primary data. The text functions primarily as an academic rebuttal or clarification within the ongoing discourse on the disease. This paper is centrally about endometriosis — specifically serving as a scholarly reply concerning the condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,162 characters · extracted from oa-html · click to expand
Journal article : Letter Endometriosis: the authors reply - Publication status: - Published - Peer review status: - Peer reviewed Actions Access Document - Files: - - (Preview, Accepted manuscript, pdf, 71.2KB, Terms of use) - - Publisher copy: - 10.1056/nejmc2013221 Authors - Publisher: - Massachusetts Medical Society - Journal: - New England Journal of Medicine More from this journal - Volume: - 383 - Issue: - 2 - Pages: - 194 - Publication date: - 2020-07-09 - Acceptance date: - 2020-06-22 - DOI: - EISSN: - 1533-4406 - ISSN: - 0028-4793 - Pmid: - 32640140 - Language: - English - Keywords: - Subtype: - Letter - Pubs id: - 1119329 - Local pid: - pubs:1119329 - Deposit date: - 2021-07-12 - ARK identifier: Terms of use - Copyright holder: - Massachusetts Medical Society - Copyright date: - 2020 - Rights statement: - Copyright © 2020 Massachusetts Medical Society. - Notes: - This is the accepted manuscript version of the article. The final version is available online from the Massachusetts Medical Society at: https://doi.org/10.1056/NEJMc2013221 If you are the owner of this record, you can report an update to it here: Report update to this record

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Female Female Humans Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

Cited by (14)

Source provenance

europepmc
last seen: 2026-11-12T06:12:04.065205+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:27:56.761287+00:00
unpaywall
last seen: 2026-11-05T06:08:55.941966+00:00
License: CC0 · commercial use OK